IRIS
MURA, Maria Stella Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.977
AS - Asia 1.789
EU - Europa 1.112
SA - Sud America 1.061
AF - Africa 58
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 8
Totale 7.015
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.919
BR - Brasile 966
SG - Singapore 724
CN - Cina 612
UA - Ucraina 389
DE - Germania 170
HK - Hong Kong 149
SE - Svezia 114
FR - Francia 81
IT - Italia 79
GB - Regno Unito 72
FI - Finlandia 68
VN - Vietnam 57
IN - India 37
IQ - Iraq 30
RU - Federazione Russa 30
AR - Argentina 28
BD - Bangladesh 26
MX - Messico 25
TR - Turchia 25
EC - Ecuador 20
ES - Italia 20
BE - Belgio 19
CZ - Repubblica Ceca 16
CA - Canada 15
ZA - Sudafrica 15
IR - Iran 14
PL - Polonia 14
PK - Pakistan 13
VE - Venezuela 12
CO - Colombia 11
KR - Corea 11
MA - Marocco 11
AE - Emirati Arabi Uniti 10
JO - Giordania 10
TN - Tunisia 10
JP - Giappone 8
PE - Perù 8
UZ - Uzbekistan 8
AT - Austria 7
ID - Indonesia 7
PY - Paraguay 7
AU - Australia 6
AZ - Azerbaigian 6
NP - Nepal 6
EU - Europa 5
KE - Kenya 5
KZ - Kazakistan 5
LT - Lituania 5
UY - Uruguay 5
BG - Bulgaria 4
CR - Costa Rica 4
EG - Egitto 4
IL - Israele 4
KG - Kirghizistan 4
NG - Nigeria 4
OM - Oman 4
PA - Panama 4
RO - Romania 4
SA - Arabia Saudita 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
GT - Guatemala 3
IE - Irlanda 3
NL - Olanda 3
QA - Qatar 3
RS - Serbia 3
CH - Svizzera 2
CL - Cile 2
DZ - Algeria 2
HN - Honduras 2
JM - Giamaica 2
KW - Kuwait 2
MD - Moldavia 2
PT - Portogallo 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
KI - Kiribati 1
LB - Libano 1
MM - Myanmar 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PS - Palestinian Territory 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 7.014
Salva come PNG Salva come JPEG
Città #
Dallas 1.077
Singapore 435
Chandler 380
Jacksonville 236
Hong Kong 149
Beijing 143
Princeton 130
Nanjing 102
Ashburn 72
Dearborn 68
Ann Arbor 60
São Paulo 54
New York 53
Wilmington 52
Boardman 49
Shanghai 44
Nanchang 43
Shenyang 41
Los Angeles 34
Rio de Janeiro 33
Woodbridge 30
Sassari 28
Munich 25
Tianjin 25
Belo Horizonte 24
Hebei 23
Ho Chi Minh City 23
Curitiba 22
Santa Clara 21
Ningbo 20
Brussels 19
Columbus 19
Jinan 18
Changsha 16
Porto Alegre 16
The Dalles 16
Brasília 15
Warsaw 14
Zhengzhou 14
Brno 13
Buffalo 13
Council Bluffs 13
London 13
Nuremberg 13
Ardabil 12
Brooklyn 12
Guangzhou 12
Hanoi 12
Madrid 12
Baghdad 11
Hangzhou 11
Seoul 11
Amman 10
Andover 10
Chennai 10
Houston 10
Norwalk 10
Poplar 10
Dhaka 9
Kunming 9
San Francisco 9
Campinas 8
Denver 8
Guarulhos 8
Leawood 8
Natal 8
Orem 8
Ribeirão Preto 8
Rome 8
São Bernardo do Campo 8
Tashkent 8
Tunis 8
Turku 8
Uberlândia 8
Changchun 7
Helsinki 7
Izmir 7
Juiz de Fora 7
Monmouth Junction 7
Mumbai 7
Recife 7
San Mateo 7
Taizhou 7
Auburn Hills 6
Augusta 6
Baku 6
Campo Grande 6
Fortaleza 6
Johannesburg 6
João Pessoa 6
Montreal 6
Osasco 6
Sumaré 6
São José do Rio Preto 6
Toronto 6
Aparecida de Goiânia 5
Atlanta 5
Betim 5
Blumenau 5
Boston 5
Totale 4.152
Salva come PNG Salva come JPEG
Nome #
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 261
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 197
Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis 191
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome 189
Analisi delle Dual Therapy nei pazienti con HIV: Aspetti farmacoeconomici-epidemiologici e clinici 171
Ebola virus disease: Case management in the Institute of Infectious Diseases, University Hospital of Sassari, Sardinia, Italy. 170
Acute respiratory distress syndrome due to influenza virus A/H1N1v in a patient with HIV/HCV co-infection 158
Mucocutaneous leishmniasis as presentation of HIV infection in Sardinia, insular Italy 157
Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era 154
Associazione sierologia tra HIV e Trichomonas vaginalis nella popolazione femminile del Nord-Sardegna. 147
Dental care and HIV-infected individuals: are they equally treated? 142
Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy 138
13. Socio-demographic and climatic factors as correlates of Mediterranean spotted fever (MSF) in northern Sardinia. 138
Trends in the European HIV/AIDS epidemic: a perspective from Italy 137
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study. 135
Andamento delle infezioni nosocomiali nel complesso chirurgico Università- Azienda USL n. 1- Sassari. 131
Tenofovir renal safety in HIV-infected patients: results from the SCOLTA Project 129
Identification of HIV patients with active pulmonary tuberculosis using urine based polymerase chain reaction assay 128
Arboviral infections in Egyptian and Sardinian children and adults with aseptic meningitis and meningo-encephalitis 127
Body composition change in hiv-infected patients treated with HAART: a longitudinal DEXA study. 127
Pneumococcal pneumonia: clinical features, diagnosis and management in HIV-infected and HIV non infected patients 125
Body composition evaluation by DEXA in the follow up of HIV patients treted with HAART. 125
Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era? 125
DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy 124
Access to antiretroviral treatment, incidence of sustained therapy interruptions, and risk of clinical events according to sex: evidence from the I.Co.N.A. Study. 123
Proteomic characterization of hepatitis C eradication: enzyme switch in the healing liver. 119
Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era 118
Body fat changes and mitochondrial alterations during HBV treatment: A warning for long term administration. 117
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin 115
QuantiFERON TB Gold: a new method for latent tuberculosis infection 112
Mediterranean spotted fever-like illness in Sardinia, Italy: a clinical and microbiological study 111
Timing of antiretroviral therapy initiation after a first AIDS-defining event: temporal changes in clinical attitudes in the ICONA cohort 109
Risk factors and occurrence of rash in HIV-positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside-experienced patients with very low CD4 levels (<50 cells/microL) 109
Rapid detection and identification of Mycobacterium tuberculosis by Real Time PCR and Bactec 960 MIGT 108
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? 104
Renal toxicity in HIV-infected patients receiving HAART including tenofovir 99
Comparison of the efficacy at 48 weeks of first-line antiretroviral treatment for HIV infection in 1998 and 2006: a multicentric investigation 99
Interferon-γ release assay in people infected with immunodeficiency virus 98
Hepatitis E virus and hepatitis A virus exposures in an apparently healthy high-risk population in Italy. 98
Molecular typing of non-typhoid Salmonella strains isolated from HIV-infected patients with recurrent salmonellosis 88
Raltegravir central nervous system tolerability in clinical practice: results from a multicenter observational study 88
Hepatitis C Viremia in HIV/HCV-Coinfected Patients: Lower Levels in Presence of Chronic Hepatitis B 87
Usefulness of 99mTc-tetrofosmin scintigraphy in different variants of Kaposi's sarcoma. 87
The changing face of the HIV epidemic in Northern Sardinia: increased diagnoses among pregnant women 87
Rotavirus infection in AIDS-associated diarrhoea. 85
Distribution of the CCR5 delta32 allele in Italian HIV type 1-infected and normal individuals 83
Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy (HAART): a longitudinal study 82
Severe liver disease associated with prolonged exposure to antiretroviral drugs 81
Detection of Toscana virus central nervous system infections in Sardinia Island, Italy. 81
The HIV/AIDS epidemic in the Province of Sassari in the combination antiretroviral therapy era 76
Rickettsia monacensis as Cause of Mediterranean Spotted Fever-like Illness, Italy 75
HPV infection in HIV-positive females: the need for cervical cancer screening including HPV-DNA detection despite successful HAART 74
HIV and related infections in Italian prisons: epidemiology and health organization 73
Serum leptin and bone metabolism in HIV patients treated with highly active antiretroviral therapy 68
Timing of antiretroviral therapy initiation after a first AIDS-defining event: temporal changes in clinical attitudes in the ICONA cohort 67
Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR 63
Treatment-related factors and highly active antiretroviral therapy adherence. 60
HIV type 1 origin and transmission dynamics among different risk groups in sardinia: molecular epidemiology within the close boundaries of an Italian island 60
Successful prevention of multidrug resistant HIV mother-to-child transmission with enfuvirtide use in late pregnancy 59
Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection 59
Minor mutations in HIV protease at baseline and appearance of primary mutation 90M in patients for whom their first protease-inhibitor ntiretroviral regimens failed 59
L'Epidemia da HIV/AIDS in Provincia di Sassari nell'era della terapia antiretrovirale combinata 58
Prevalence and risk factors for chronic obstructive lung disease in HIV-infected patients in the HAART era 57
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome. 50
Two cases of human granulocytic ehrlichiosis in Sardinia, Italy confirmed by PCR 47
Efficacy of 1998vs2006 first-line antiretroviral regimens for HIV infection: an ordinary clinics retrospective investigation 42
Totale 7.161
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.210
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.210
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021329 0 0 0 0 0 26 63 3 84 77 64 12
2021/2022309 52 6 4 6 6 7 16 18 19 18 29 128
2022/2023694 69 53 10 145 53 129 0 57 123 10 24 21
2023/2024172 38 13 2 6 32 18 0 8 0 0 16 39
2024/20251.946 24 22 109 42 66 52 133 351 683 290 99 75
2025/20262.274 137 869 433 399 296 140 0 0 0 0 0 0
Totale 7.161